GLP-1 drugs semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and their competitors have demonstrated clinical efficacy for weight loss, type 2 diabetes management, and cardiovascular risk reduction that is genuinely transformative
The 2.4mg weekly dose produced an average 14.9% body weight reduction at 68 weeks in participants with obesity, a number that at the time seemed extraordinary
Sin embargo, presenta unas cuantas formas diferentes y trabaja con una enzima que tiene un nombre muy similar
Liu, Z., et al
Increased oxidative phosphorylation in response to acute and chronic DNA damage
It can trigger a specific appetite for relevant foods, known as sensory-specific appetite, helping us detect and respond to food in our environment